Aptevo Therapeutics Inc (APVO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
3,421,300
EV to revenue ratio (TTM)
0.001
EV to ebitda
0.386
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
345,000
EBITDA
-26,689,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-111.50%
Return on equity (TTM)
-420.30%
Per Share Metrics
Revenue per share (TTM)
0
EPS
456.62
Diluted EPS (TTM)
456.62
Book value
4.26
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
0.004
Trailing P/E
0.004
Forward P/E
3.889
PEG ratio
0
Price to sales ratio (TTM)
2.704
Price to book ratio (TTM)
0.566
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.611